COMPARISON OF CLINICAL RESPONSE BETWEEN SIX AND EIGHT CYCLES OF CHOP CHEMOTHERAPY IN NON HODGKIN LYMPHOMA
Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2018, Vol 5, Issue 1
Abstract
Background: Non Hodgkin lymphoma is one of the ten most common cancers in the developed world, it is one of the commonest malignancies in Sudan. There are a lot of treatment modalities used. This study is conducted to compare clinical response to six and eight cycles of CHOP chemotherapy among adult Sudanese patients with Non-Hodgkin lymphoma. Methods: Sixty five patients above 18 years of age with Non-Hodgkin lymphoma, attending oncology hospital from June to August 2016, treated with either six or eight cycles of CHOP chemotherapy recruited for this study. These patients have been followed up for six months. The data were collected using a standard structured questionnaire. The collected data were analyzed by SPSS software (version 19). Results: There was a significant difference in clinical responses of B symptoms, lymphadenopathy and splenomegaly between six and eight cycles of CHOP chemotherapy. In observing hepatomegaly, no significant difference was observed in response to CHOP after both six & eight cycles. Conclusion: This study concluded that, regarding the lymphadenopathy, splenomegaly and B symptoms (fever, sweating and weight loss), there was a marked improvement after eight cycles.
Authors and Affiliations
Prof. Sana E. Abdalla
OVARIAN SERTOLI-LEYDIG CELL TUMOR: REPORT OF A RARE CASE
Ovarian Sertoli-Leydig cell tumors (SLCT) are extremely rare ovarian tumors belonging to the group of sex cord-stromal tumors and divided into four subtypes, that are well differentiated, moderately differentiated, poorl...
MORPHOMETRIC STUDY OF THE ADULT HUMAN BRAIN VENTRICULAR SIZES ON COMPUTED TOMOGRAPHY SCANS IN NIGERIAN.
Background: Aging as well as pathological conditions are associated with gross brain changes leading to enlargement of the ventricles. Knowledge of the normal ventricular sizes is important to understanding these changes...
DETERMINATION OF MYC GENES MUTATIONS IN PATIENTS WITH LEUKEMIA FROM TURKEY
Myc oncogenes are contributing to the development of cancer, and many of the genes to become active. Studies on the expression of these genes has led to the development of new therapies for the treatment of cancer patien...
THE OCCUPATIONAL RISK FACTORS FOR CANCER: A SURVEY AMONG THE ARTISANS IN THE CITY OF FEZ (MOROCCO)
Cancer is the second leading cause of mortality in Morocco. Data on occupational exposure related to cancer are still lacking. The objective of this study was to determine the frequency and the significance of the exposu...
THE EFFECT OF COMPETITIVE AND NONCOMPETIVE ANTAGONIST OF ASPARTATE ON THE SURVIVAL TIME OF MICE WITH EXPERIMENTAL TETANUS
Tetanus is dangerous, infectious, noncontagious, acute and mostly afebrile illness of humans and different animal species, which is caused by Gram positive, ubiqutarious anaerobic Clostridium tetani. It produces a specif...